Everybody's welcome: The big tent approach to epigenetic drug discovery

Drug Discovery Today: Therapeutic Strategies

Volumn 9, Issue 2-3, 2012, Pages

  Green, Erin M ^a   Gozani, Or ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; APICIDIN; AZACITIDINE; BELINOSTAT; BINDING PROTEIN; CHROMATIN BINDING PROTEIN; HISTONE; HISTONE LYSINE METHYLTRANSFERASE; MG 98; MOCETINOSTAT; NSD PROTEIN; PROCAINE; PROTEIN; ROMIDEPSIN; TRICHOSTATIN A; UNCLASSIFIED DRUG; VALPROIC ACID; VORINOSTAT; ZEBULARINE;

DEACETYLATION; DNA METHYLATION; DNA MODIFICATION; DNA REPLICATION; DNA SEQUENCE; DNA TRANSCRIPTION; EPIGENETICS; GENE EXPRESSION; HISTONE METHYLATION; HUMAN; NONHUMAN; PROTEIN PROCESSING; REVIEW;

EID: 84871428303     PISSN: None     EISSN: 17406773     Source Type: Journal    
DOI: 10.1016/j.ddstr.2011.08.002     Document Type: Review

References (53)

1. Waddington, C.H. (1942) The epigenotype. Endeavour 1, 18-20
2. Riggs, A.D., Martienssen, R.A., Russo, V.E.A., eds) (1996) Overview of Epigenetic Mechanisms, Cold Spring Harbor Laboratory Press
3. Li, G. and Reinberg, D. (2011) Chromatin higher-order structures and gene regulation. Curr. Opin. Genet. Dev. 21, 175-186
4. Probst, A.V. et al. (2009) Epigenetic inheritance during the cell cycle. Nat. Rev. Mol. Cell Biol. 10, 192-206
5. Bernstein, B.E. et al. (2007) The mammalian epigenome. Cell 128, 669-681 (Pubitemid 46273573)
6. Kouzarides, T. (2007) Chromatin modifications and their function. Cell 128, 693-705 (Pubitemid 46273577)
7. Shi, Y. and Whetstine, J.R. (2007) Dynamic regulation of histone lysine methylation by demethylases. Mol. Cell 25, 1-14 (Pubitemid 46049067)
8. Taverna, S.D. et al. (2007) How chromatin-binding modules interpret histone modifications: lessons from professional pocket pickers. Nat. Struct. Mol. Biol. 14, 1025-1040 (Pubitemid 350060344)
9. Lan, F. et al. (2007) Recognition of unmethylated histone H3 lysine 4 links BHC80 to LSD1-mediated gene repression. Nature 448, 718-722 (Pubitemid 47236862)
10. Kurdistani, S.K. (2011) Histone modifications in cancer biology and prognosis. Prog. Drug Res. 67, 91-106
11. Seligson, D.B. et al. (2009) Global levels of histone modifications predict prognosis in different cancers. Am. J. Pathol. 174, 1619-1628
12. Rodriguez-Paredes, M. and Esteller, M. (2011) Cancer epigenetics reaches mainstream oncology. Nat. Med. 330-339
13. Ellis, L. et al. (2009) Epigenetics in cancer: targeting chromatin modifications. Mol. Cancer Ther. 8, 1409-1420
14. Hatziapostolou, M. and Iliopoulos, D. (2011) Epigenetic aberrations during oncogenesis. Cell. Mol. Life Sci. 68, 1681-1702
15. Ganesan, A. et al. (2009) Epigenetic therapy: histone acetylation, DNA methylation and anti-cancer drug discovery. Curr. Cancer Drug Targets 9, 963-981
16. Gore, S.D. et al. (2006) Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms. Cancer Res. 66, 6361-6369
17. Garcia-Manero, G. et al. (2006) Phase 1/2 study of the combination of 5-aza-2-deoxycytidine with valproic acid in patients with leukemia. Blood 108, 3271-3279
18. Nolan, L. et al. (2008) Will histone deacetylase inhibitors require combination with other agents to fulfil their therapeutic potential quest. Br. J. Cancer 99, 689-694
19. Albert, M. and Helin, K. (2010) Histone methyltransferases in cancer. Semin. Cell Dev. Biol. 21, 209-220
20. Tan, J. et al. (2007) Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells. Genes Dev. 21, 1050-1063 (Pubitemid 46686474)
21. Su, I.H. et al. (2003) Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement. Nat. Immunol. 4, 124-131
22. Ezhkova, E. et al. (2009) Ezh2 orchestrates gene expression for the stepwise differentiation of tissue-specific stem cells. Cell 136, 1122-1135
23. Schaefer, A. et al. (2009) Control of cognition and adaptive behavior by the GLP/G9a epigenetic suppressor complex. Neuron 64, 678-691
24. Levy, D. et al. (2011) Lysine methylation of the NF-kappaB subunit RelA by SETD6 couples activity of the histone methyltransferase GLP at chromatin to tonic repression of NF-kappaB signaling. Nat. Immunol. 12, 29-36
25. Saccani, S. and Natoli, G. (2002) Dynamic changes in histone H3 Lys 9 methylation occurring at tightly regulated inducible inflammatory genes. Genes Dev. 16, 2219-2224 (Pubitemid 35013084)
26. van Essen, D. et al. (2010) A feed-forward circuit controlling inducible NF-kappaB target gene activation by promoter histone demethylation. Mol. Cell 39, 750-760
27. Greiner, D. et al. (2005) Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9. Nat. Chem. Biol. 1, 143-145
28. Kubicek, S. et al. (2007) Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase. Mol. Cell 25, 473-481 (Pubitemid 46206139)
29. Chang, Y. et al. (2010) Adding a lysine mimic in the design of potent inhibitors of histone lysine methyltransferases. J. Mol. Biol. 400, 1-7
30. Douglas, J. et al. (2004) Evaluation of NSD2 and NSD3 in overgrowth syndromes. Eur. J. Hum. Genet. 13, 150-153
31. Nimura, K. et al. (2009) A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf-Hirschhorn syndrome. Nature 460, 287-291
32. Kurotaki, N. et al. (2002) Haploinsufficiency of NSD1 causes Sotos syndrome. Nat. Genet. 30, 365-366
33. Wang, G.G. et al. (2007) NUP98-NSD1 links H3, K36 methylation to Hox-A gene activation and leukaemogenesis. Nat. Cell Biol. 9, 804-812 (Pubitemid 47019467)
34. Rosati, R. et al. (2002) NUP98 is fused to the NSD3 gene in acute myeloid leukemia associated with t(8;11)(p11.2;p15). Blood 99, 3857-3860 (Pubitemid 34534564)
35. Taketani, T. et al. (2009) NUP98-NSD3 fusion gene in radiation-associated myelodysplastic syndrome with t(8;11)(p11;p15) and expression pattern of NSD family genes. Cancer Genet. Cytogenet. 190, 108-112
36. Chesi, M. et al. (1998) The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts. Blood 92, 3025-3034 (Pubitemid 28492306)
37. Li, Y. et al. (2009) The target of the NSD family of histone lysine methyltransferases depends on the nature of the substrate. J. Biol. Chem. 284, 34283-34295
38. Pei, H. et al. (2011) MMSET regulates histone H4K20 methylation and 53BP1 accumulation at DNA damage sites. Nature 470, 124-128
39. Kim, J-Y. et al. (2008) Multiple myeloma-related WHSC1/MMSET isoform RE-IIBP is a histone methyltransferase with transcriptional repression activity. Mol. Cell. Biol. 28, 2023-2034 (Pubitemid 351342632)
40. Kuo, A.J. et al. (2011) NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming. Mol. Cell
41. Milne, T.A. et al. (2002) MLL targets SET domain methyltransferase activity to Hox gene promoters. Mol. Cell 10, 1107-1117 (Pubitemid 35453828)
42. Krivtsov, A.V. and Armstrong, S.A. (2007) MLL translocations, histone modifications and leukaemia stem-cell development. Nat. Rev. Cancer 7, 823-833 (Pubitemid 350006257)
43. Nakamura, T. et al. (2002) ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation. Mol. Cell 10, 1119-1128 (Pubitemid 35453829)
44. Mueller, D. et al. (2009) Misguided transcriptional elongation causes mixed lineage leukemia. PloS Biol. 7, e1000249
45. Okada, Y. et al. (2005) hDOT1L links histone methylation to leukemogenesis. Cell 121, 167-178 (Pubitemid 40546386)
46. Bernt, K.M. et al. (2011) MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L. Cancer Cell 20, 66-78
47. Daigle, S.R. et al. (2011) Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor. Cancer Cell 20, 53-65
48. Guy, J. et al. (2007) Reversal of neurological defects in a mouse model of Rett syndrome. Science 315, 1143-1147 (Pubitemid 46328028)
49. Nicodeme, E. et al. (2010) Suppression of inflammation by a synthetic histone mimic. Nature 468, 1119-1123
50. Filippakopoulos, P. et al. (2010) Selective inhibition of BET bromodomains. Nature 468, 1067-1073
51. Spannhoff, A. et al. (2009) The emerging therapeutic potential of histone methyltransferase and demethylase inhibitors. ChemMedChem 4, 1568-1582
52. Li, F. et al. (2011) Coordination of DNA replication and histone modification by the Rik1-Dos2 complex. Nature 475, 244-248
53. Radman-Livaja, M. et al. (2011) Patterns and mechanisms of ancestral histone protein inheritance in budding yeast. PloS Biol. 9, e1001075